Search Results - "Fang, Bruno S."
-
1
Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer
Published in American journal of clinical oncology (01-04-2018)“…The aim of this study is to investigate the impact of missed chemotherapy administrations (MCA) on the prognosis of non-small cell lung cancer (NSCLC) patients…”
Get full text
Journal Article -
2
BRCA1-Associated Growth Arrest Is RB-Dependent
Published in Proceedings of the National Academy of Sciences - PNAS (12-10-1999)“…BRCA1 is a susceptibility gene for breast and ovarian cancer with growth-inhibitory activity for which the mechanism of action remains unclear. When introduced…”
Get full text
Journal Article -
3
Ibrutinib Dose Reductions and Discontinuations Patterns Among Patients with Chronic Lymphocytic Leukemia from a Large Community Medical Oncology Practice
Published in Blood (05-11-2020)“…Introduction: Ibrutinib is a Bruton tyrosine kinase inhibitor approved for the treatment of first-line (1L) and relapsed/refractory (R/R) chronic lymphocytic…”
Get full text
Journal Article -
4
Dose Reductions and Discontinuations with Chronic Lymphocytic Leukemia (CLL) Patients Receiving Ibrutinib in Community and Academic Settings
Published in Blood (05-11-2020)“…Introduction: Since its approval in 2014, ibrutinib has replaced chemotherapy to become a preferred therapy for CLL patients. Real-world studies of ibrutinib…”
Get full text
Journal Article -
5
Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome
Published in American journal of hematology (01-07-2000)“…The occurrence of factor VIII inhibitors in non‐hemophilic patients is a rare event with a potentially lethal outcome. Despite its infrequent occurrence, the…”
Get full text
Journal Article